This report is designed to be a helpful business tool that provides a thorough evaluation of the market for influenza vaccines, therapeutics and diagnostics. The geographic scope of this study is global, with emphasis on U.S. and European data.
The report identifies markets in general segments: Vaccines, Therapeutics and Diagnostics. Each market segment discussion provides detailed information based on product categories, uses of products, forecasts and competitive analyses. Additionally, the study covers some of the most significant issues, trends and market factors.
- 25 data tables and 77 additional tables
- An overview of the global influenza market
- Analyses of global market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Identification of segments with high growth potential and their future applications
- Explanation of major drivers and regional dynamics of the market and current trends within the industry
Key Topics Covered:
2 Summary And Highlights
3 Industry Overview And Background
4 Global Influenza Vaccine Market
5 Global Influenza Therapeutics Market
6 Global Influenza Diagnostic Market
7 Influenza Pandemic Impact
8 Patent Review/ New Developments
9 Analysis Of Market Opportunities
10 Company Profiles
- Alere Inc.
- Medimmune Inc.
- Becton Dickinson And Company
- Daiichi Sankyo
- Glaxosmithkline Plc
- Hologic Inc
- Luminex Corp.
- Mitsubishi Tanabe Pharma Corp.
- Mylan N.V.
- Orasure Technologies
- Qiagen N.V.
- Quidel Corp.
- Sanofi/Sanofi Pasteur
- Sekisui Diagnostics Llc
For more information about this report visit https://www.researchandmarkets.com/research/t93mxs/global_influenza?w=4